Skip to search formSkip to main contentSkip to account menu

conivaptan Injection [Vaprisol]

National Institutes of Health

Related topics

Related topics

2 relations
InjectionVaprisol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
ASTELLAS LAUNCHES VAPRISOL ® (CONIVAPTAN HYDROCHLORIDE INJECTION) PREMIXED IN 5% DEXTROSE FOR THE TREATMENT OF HYPONATREMIA Arginine vasopressin (AVP) receptor antagonist now available in new…
DEERFIELD, Illinois, April 1, 2009 — Astellas Pharma US, Inc. today announced the commercial availability of Vaprisol (conivaptan… 
Review
2008
Review
2008
Treatment of Hyponatremia in Cirrhosis
Letter to the Editor In his review article, Dr. Mahesh [1] discussed the pathophysiology and management of hyponatremia in… 
2008
2008
FDA APPROVES ASTELLAS' VAPRISOL ® (CONIVAPTAN HYDROCHLORIDE INJECTION) PREMIXED IN 5% DEXTROSE FOR THE TREATMENT OF HYPONATREMIA Arginine vasopressin (AVP) receptor antagonist now approved in single…
DEERFIELD, Illinois, October 22, 2008 — Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration (FDA…